Post-ERCP pancreatitis prevention — ESEGH MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Rectal diclofenac or indometacin with consideration of prophylactic pancreatic duct stenting
Rectal NSAIDs reduce post-ERCP pancreatitis risk, and pancreatic duct stenting is considered in high-risk cases such as repeated pancreatic duct cannulation. Antibiotics prevent selected infectious complications, not pancreatitis. Opioids treat pain but do not prevent pancreatitis. The pearl is that post-ERCP pancreatitis prevention should be planned before and during the procedure.
Reference: ESGE ERCP-related Adverse Events Guideline; BSG ERCP Guidance